Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications

The link between the anti-Parkinsonian drug L-3,4-dihydroxyphenylalanine (L-DOPA) and the serotonergic (5-HT) system has been long established and has received increased attention during the last decade. Most studies have focused on the fact that L-DOPA can be transformed into dopamine (DA) and rele...

Descripción completa

Detalles Bibliográficos
Autores principales: Miguelez, Cristina, Benazzouz, Abdelhamid, Ugedo, Luisa, De Deurwaerdère, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600927/
https://www.ncbi.nlm.nih.gov/pubmed/28955204
http://dx.doi.org/10.3389/fncel.2017.00274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600927/
https://www.ncbi.nlm.nih.gov/pubmed/28955204
http://dx.doi.org/10.3389/fncel.2017.00274

Ejemplares similares